Valuation AstraZeneca PLC

Equities

Market Closed - London S.E. Other stock markets 10:05:13 13/02/2026 pm IST			5-day change	1st Jan Change
15,118.00 ^GBX	+1.42%		+7.19%	+9.63%

14/02	Sector Update: Health Care Stocks Advance Late Afternoon	MT
14/02	Sector Update: Health Care Stocks Higher Friday Afternoon	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	1,31,259	1,82,034	2,09,442	2,09,268	2,03,171	3,19,566	3,19,566	-
Change	-	38.68%	15.06%	-0.08%	-2.91%	57.29%	0%	-
Enterprise Value (EV) ¹	1,43,126	2,06,417	2,32,365	2,31,778	2,27,741	3,11,187	3,38,344	3,30,829
Change	-	44.22%	12.57%	-0.25%	-1.74%	36.64%	-0.91%	-2.22%
P/E ratio	41x	1,469x	64.1x	35.4x	29.1x	28.4x	26.2x	23.1x
PBR	8.4x	4.24x	5.65x	5.39x	5.02x	5.96x	6.05x	5.3x
PEG	-	-15.2x	0x	0.4x	1.6x	0.6x	1.1x	1.7x
Capitalization / Revenue	4.93x	4.87x	4.72x	4.57x	3.76x	4.9x	5.12x	4.82x
EV / Revenue	5.38x	5.52x	5.24x	5.06x	4.21x	5.3x	5.42x	4.99x
EV / EBITDA	17.2x	27.2x	25.2x	17.1x	13.6x	16x	14.9x	13.3x
EV / EBIT	19.5x	20.8x	17.4x	15.9x	13.5x	16.8x	16.1x	14.2x
EV / FCF	37.3x	42.4x	26.7x	25.8x	22.9x	26.5x	30.9x	24.2x
FCF Yield	2.68%	2.36%	3.75%	3.88%	4.36%	3.78%	3.23%	4.14%
Dividend per Share ²	2.8	2.87	2.9	2.9	3.1	3.2	3.329	3.541
Rate of return	2.8%	2.44%	2.15%	2.15%	2.37%	1.72%	1.62%	1.72%
EPS ²	2.44	0.08	2.11	3.81	4.5	6.54	7.879	8.926
Distribution rate	115%	3,588%	137%	76.1%	68.9%	48.9%	42.3%	39.7%
Net sales ¹	26,617	37,417	44,351	45,811	54,073	58,739	62,405	66,320
EBITDA ¹	8,311	7,586	9,237	13,580	16,691	19,476	22,730	24,853
EBIT ¹	7,340	9,928	13,350	14,534	16,928	18,478	21,065	23,370
Net income ¹	3,196	112	3,288	5,961	7,035	10,225	12,440	14,006
Net Debt ¹	11,867	24,383	22,923	22,510	24,570	23,374	18,779	11,263
Reference price ²	99.99	117.51	135.16	135.02	131.05	206.05	206.05	206.05
Nbr of stocks (in thousands)	13,12,660	15,49,159	15,49,528	15,49,926	15,50,317	15,50,945	15,50,945	-
Announcement Date	11/02/21	10/02/22	09/02/23	08/02/24	06/02/25	10/02/26	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASTRAZENECA PLC	32.49x	5.82x	17.36x	1.58%	32TCr
ELI LILLY AND COMPANY	31.13x	11.79x	23.7x	0.63%	93TCr
JOHNSON & JOHNSON	22.11x	6.52x	18.12x	2.12%	59TCr
ABBVIE INC.	64.64x	7.64x	18.92x	2.82%	41TCr
ROCHE HOLDING AG	18.87x	4.7x	11.65x	2.79%	37TCr
NOVARTIS AG	21.47x	6x	14.69x	2.7%	31TCr
MERCK & CO., INC.	15.68x	5.03x	10.97x	2.66%	30TCr
NOVO NORDISK A/S	14.81x	5.11x	10.76x	3.49%	22TCr
AMGEN INC.	28.69x	6.7x	11.46x	2.59%	20TCr
GILEAD SCIENCES, INC.	22.73x	7.03x	12.85x	2.14%	19TCr
Average	27.26x	6.63x	15.05x	2.35%	38.41TCr
Weighted average by Cap.	28.77x	7.47x	16.99x	2.05%